We’re approving historic levels of cancer-treating drugs: Alex Azar
Secretary of Health and Human Services Alex Azar discusses President Trump’s assertion that cancer death rates are at their lowest rate on record and Trump wanting the Supreme Court to hold off on their Obamacare ruling until after the 2020 presidential election.
There may be hope for an effective plant-based treatment for various head and neck cancers, according to a new study conducted by researchers at UCLA.
Continue Reading Below
The organization posted an update to its findings in the last week, which aims to treat the 650,000 cases that are diagnosed across the globe every year.
Instead of relying on more aggressive treatment methods such as radiation, chemotherapy and surgery – which are used on advanced cases – researchers have conducted a phase I clinical trial that is meant to be a less invasive method for treating oral and throat cancers.
FDA-APPROVED STOMACH CANCER DRUG SENDS BLUEPRINT MEDICINES’ STOCK UP BEFORE RESETTLING
The APG-157 drug that has been developed in the trial is considered a "botanical drug," according to UCLA's press release, and primarily includes curcumin, an ingredient that is found in popular household spice known as turmeric. There are other botanicals in APG-157, however, researchers have determined that the antioxidants and anti-inflammatory properties in curcumin are helpful in fighting cancer.
Natural consumption of curcumin through turmeric does not readily absorb into the bloodstream, according to the study. But, researchers at UCLA are suggesting that APG-157 can be effective if it is formulated as a lozenge.